Abstract Aim: Assessment of the clinical and haematological course of autoimmune neutropenia of infancy (ANI) in a defined childhood population in the south east of
tent neutropenia were examined serologically for evidence of antigranulocyte antibodies. The clinical course of those children found to have anti-granulocyte antibodies was then closely monitored. Results: During the study period five children had serologically confirmed ANI, giving an annual incidence of approximately 1/100 000 in this population. All of these cases followed the classic benign course of the condition. The presenting illnesses were mild, often with superficial skin sepsis and the initial absolute neutrophil count (ANC) ranged from 0-00-0-87 x 10'/I. All fraction were lysed using a hypo-osmolar solution of ammonium oxalate. Granulocytes were inactivated by incubation at 52°C for 2 minutes prior to incubation with test serum and were not treated with paraformaldehyde.
Target granulocytes and lymphocytes were obtained from normal donors typed for the neutrophil specific antigens NAI, NA2, and NB1, the tissue antigen 5b and HLA-A and B antigens. Granulocyte immunofluorescence was used to determine NA1, NA2, NB1, and 5b phenotype and lymphocytotoxicity was used to determine HLA-A and B phenotypes.
Results
During the study period, within the Lothian region of Scotland which has a childhood population of just over 96 000 aged from 0-10 years, five children presented with serologically confirmed ANI (table 1). Three were female and the median age at diagnosis was 8 months (range 7-13 months). They all presented with minor illnesses, and in three there was skin sepsis. All had absolute neutropenia with ANC ranging from 0 00-0-87 x 109/1, case 4 also had iron deficiency anaemia. Bone marrow examination of these patients confirmed an increased M:E ratio with "left shift" ofthe myeloid series but no specific arrest patterns. In cases 1-3 there appeared to be an initial elevated T4:T8 lymphocyte subset ratio which normalised with time. Serum immunoglobulin concentrations were normal.
The anti-granulocyte antibodies detected were of the IgG class but weakly reactive IgM antibodies were also detected in one patient. In three patients the anti-granulocyte antibodies were specific for the NAI antigen. Anti-HLA antibodies were not detected.
In cases 1 and 5 the neutropenia has resolved after 14 and 24 months respectively; in the other three cases neutropenia persists at present. None of these children has suffered any severe infections or any great increase in minor infections during the course of the neutropenia. Case 1 has been closely followed through to complete recovery and the clinical course of this patient demonstrates the typical features of this disorder (figure):
(1) The total white blood count always remained within normal limits.
(2) The ANC remained below 0 5 x 109/l for the first 12 months.
(3) The level of anti-granulocyte antibody activity slowly decreased during the course of the disease.
(4) Temporary increases in peripheral neutrophil counts were observed with the development of Campylobacter enteritis and an urticarial illness.
(5) The incidence of infections (five upper respiratory tract infections, two fevers, one episode of mouth ulcers and one episode of diarrhoea, in addition to the two illnesses described above) during the 24 month period of neutropenia could not be considered excessive for a child of this age.
Discussion
The five patients described in this report have clinical and laboratory features (table 1) entirely consistent with the previous reports of ANI.2-7 These five cases, from a defined geographical area, suggest that the annual incidence ofANI is in the order of 1/100 000 of the childhood population, although, because of the relatively benign course of the disorder this figure is likely to be an underestimate.
The differential diagnosis of neutropenia in infancy was recently reviewed and an algorithm for assessment of such infants described. ' deficiency, or be pure neutrophil abnormalities. This group of patients tends to present with serious infections in the very early months of life, with the exception of cyclical neutropenia which may present later with less serious infections, often superficial, and often with a positive family history."4 Clues to the acquired causes may be elicited from the history and consequent appropriate investigations.
The diagnosis of ANI depends on history and examination and upon positive serological results, although these will not be available at the time of presentation. Autoimmune neutropenia has been reported in children and adults infected with the human immunodeficiency virus, so evidence for this infection should also be sought.5 16 The bone marrow findings in ANI are not diagnostic and any process causing increased synthesis (for example, infection) or increased destruction of neutrophils (for example, alloimmune neutropenia) will give a similar picture. Marrow examination excludes neutropenia caused by proliferative disorders or aplasia.
Clinical features of autoimmune neutropenia of infancy All patients have severe neutropenia at presentation; the ANC is usually less than 0-5 x 10s/1 but the total white blood count is always within 
Conclusion
ANI is a benign condition which follows a relatively chronic course with all children recovering a normal ANC by at least 5-6 years of age. Our study suggests that the disease has an annual incidence in the order of 1/100 000 of the childhood population. The diagnosis of ANI depends on serological confirmation of anti-granulocyte antibodies. Bone marrow aspiration is mandatory to exclude other more serious causes of neutropenia.
Children symptomatically more severely affected can be treated with IVIG to improve their neutrophil count; this can be given for an acute crisis or regularly to maintain a higher ANC. The level of anti-granulocyte antibody in the serum often begins to wane prior to improvement in the ANC and this can give an indication ofwhen recovery will begin to occur. There are no known sequelae of this condition.
